Synergistic Interaction between Hyperuricemia and Abdominal Obesity as a Risk Factor for Metabolic Syndrome Components in Korean Population

다국어 초록 (Multilingual Abstract)

Background: The present study investigated the role of synergistic interaction between hyperuricemia and abdominal obesity as a risk factor for the components of metabolic syndrome.Methods: We performed a cross-sectional study using the data of 16,094 individuals from the seventh Korean National Health and Nutrition Examination Survey (2016 to 2018). The adjusted odds ratios of metabolic syndrome and its components were analyzed by multivariate logistic regression analysis. The presence of synergistic interaction between hyperuricemia and abdominal obesity was evaluated by calculating the additive scales—the relative excess risk due to interaction, attributable proportion due to interaction, and synergy index (SI).Results: There was a synergistic interaction between hyperuricemia and abdominal obesity in hypertriglyceridemia (men: SI, 1.39; 95% confidence interval [CI], 1.01 to 1.98; women: SI, 1.61; 95% CI, 1.02 to 2.69), and low high-density lipoprotein cholesterol (HDL-C) (men: SI, 2.03; 95% CI, 1.41 to 2.91; women: SI, 1.70; 95% CI, 1.05 to 2.95). There was no significant synergistic interaction between hyperuricemia and abdominal obesity for the risk of high blood pressure (men: SI, 1.22; 95% CI, 0.85 to 1.77; women: SI, 1.53; 95% CI, 0.79 to 2.97), and hyperglycemia (men: SI, 1.03; 95% CI, 0.72 to 1.47; women: SI, 1.39; 95% CI, 0.75 to 2.57).Conclusion: Hyperuricemia and abdominal obesity synergistically increased the risk of hypertriglyceridemia and low HDL-C in both sexes.

참고문헌 (Reference)

1 Kim IY, "Women with metabolic syndrome and general obesity are at a higher risk for significant hyperuricemia compared to men" 8 : 837-, 2019

2 Klein S, "Waist circumference and cardiometabolic risk : a consensus statement from shaping America’s health : Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association" 30 : 1647-1652, 2007

3 이유빈 ; 전지은 ; 이승은 ; 안지연 ; 김규리 ; 지재환 ; 배지철 ; 진상만 ; 김재현, "Utility of Serum Albumin for Predicting Incident Metabolic Syndrome According to Hyperuricemia" 대한당뇨병학회 42 (42): 529-537, 2018

4 Cirillo P, "Uric acid, the metabolic syndrome, and renal disease" 17 (17): S165-S168, 2006

5 Tsushima Y, "Uric acid secretion from adipose tissue and its increase in obesity" 288 : 27138-27149, 2013

6 Kanbay M, "Uric acid in metabolic syndrome : from an innocent bystander to a central player" 29 : 3-8, 2016

7 Sui X, "Uric acid and the development of metabolic syndrome in women and men" 57 : 845-852, 2008

8 Lee SE, "Trends in the prevalence of metabolic syndrome and its components in South Korea : findings from the Korean National Health Insurance Service Database(2009-2013)" 13 : e0194490-, 2018

9 Reaven GM, "The kidney : an unwilling accomplice in syndrome X" 30 : 928-931, 1997

10 de Mutsert R, "The effect of joint exposures : examining the presence of interaction" 75 : 677-681, 2009

11 Roberts WC, "The Friedewald-Levy-Fredrickson formula for calculating low-density lipoprotein cholesterol, the basis for lipid-lowering therapy" 62 : 345-346, 1988

12 Roncal-Jimenez CA, "Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake" 60 : 1259-1270, 2011

13 Cook DG, "Serum uric acid, serum glucose and diabetes : relationships in a population study" 62 : 1001-1006, 1986

14 Yuan H, "Serum uric acid levels and risk of metabolic syndrome : a dose-response meta-analysis of prospective studies" 100 : 4198-4207, 2015

15 Billiet L, "Review of hyperuricemia as new marker for metabolic syndrome" 2014 : 852954-, 2014

16 Hikita M, "Relationship between hyperuricemia and body fat distribution" 46 : 1353-1358, 2007

17 Kim Y, "Prevalence of hyperuricemia and its associated factors in the general Korean population : an analysis of a population-based nationally representative sample" 37 : 2529-2538, 2018

18 Soltani Z, "Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases : is it time for reappraisal?" 15 : 175-181, 2013

19 Tuomilehto J, "Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji" 127 : 321-336, 1988

20 윤연석 ; 오상우, "Optimal Waist Circumference Cutoff Values for the Diagnosis of Abdominal Obesity in Korean Adult" 대한내분비학회 29 (29): 418-426, 2014

21 Cheng YJ, "Muscle-strengthening activity and its association with insulin sensitivity" 30 : 2264-2270, 2007

22 Lim S, "Increasing prevalence of metabolic syndrome in Korea : the Korean National Health and Nutrition Examination Survey for 1998-2007" 34 : 1323-1328, 2011

23 정혜민 ; Ji Eun Moon ; 전찬홍, "Hyperuricemia is Associated With an Increased Prevalence of Metabolic Syndrome in a General Population and a Decreased Prevalence of Diabetes in Men" 대한류마티스학회 27 (27): 247-260, 2020

24 Baldwin W, "Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome" 60 : 1258-1269, 2011

25 Choi HK, "Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels: the Third National Health and Nutrition Examination Survey" 47 : 713-717, 2008

26 Matsuura F, "Effect of visceral fat accumulation on uric acid metabolism in male obese subjects : visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity" 47 : 929-933, 1998

27 Maison P, "Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature" 24 : 1758-1763, 2001

28 Miao Z, "Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China" 35 : 1859-1864, 2008

29 Grundy SM, "Diagnosis and management of the metabolic syndrome : an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement" 112 : 2735-2752, 2005

30 Kweon S, "Data resource profile : the Korea National Health and Nutrition Examination Survey(KNHANES)" 43 : 69-77, 2014

31 Shirasawa T, "Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan" 20 : 2-, 2020

32 Zhang S, "Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia" 96 : e6381-, 2017

33 Andersson T, "Calculating measures of biological interaction" 20 : 575-579, 2005

34 Yamada A, "Association of visceral fat and liver fat with hyperuricemia" 68 : 553-561, 2016

35 Rospleszcz S, "Association of serum uric acid with visceral, subcutaneous and hepatic fat quantified by magnetic resonance imaging" 10 : 442-, 2020

36 Palmer TM, "Association of plasma uric acid with ischaemic heart disease and blood pressure : mendelian randomisation analysis of two large cohorts" 347 : f4262-, 2013

37 한승진 ; Edward J. Boyko ; 김수경 ; Wilfred Y. Fujimoto ; Steven E. Kahn ; Donna L. Leonetti, "Association of Thigh Muscle Mass with Insulin Resistance and Incident Type 2 Diabetes Mellitus in Japanese Americans" 대한당뇨병학회 42 (42): 488-495, 2018

38 Lin SD, "Association between serum uric acid level and components of the metabolic syndrome" 69 : 512-516, 2006

39 정지현 ; 서영주, "Association between Serum Uric Acid and Metabolic Syndrome in Koreans" 대한의학회 34 (34): 1-9, 2019

40 Tsay YC, "Ages at onset of 5 cardiometabolic diseases adjusting for nonsusceptibility : implications for the pathogenesis of metabolic syndrome" 184 : 366-377, 2016

41 Lee SW, "Age-differential association between serum uric acid and incident hypertension" 42 : 428-437, 2019

42 Paley CA, "Abdominal obesity and metabolic syndrome : exercise as medicine?" 10 : 7-, 2018

43 VanderWeele TJ, "A tutorial on interaction" 3 : 33-72, 2014

44 Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation. Modification of Diet in Renal Disease Study Group" 130 : 461-470, 1999

45 Nakagawa T, "A causal role for uric acid in fructose-induced metabolic syndrome" 290 : F625-F631, 2006